A Bone Resorption Markers test is a specialized diagnostic blood or urine assay used to measure the rate at which bone tissue is broken down by osteoclasts.
Key markers typically evaluated include:
* C-Telopeptide (CTX): A primary fragment released into the bloodstream during the breakdown of type I collagen in bones.
* N-Telopeptide (NTX): Another collagen breakdown byproduct frequently measured in urine samples to track degradation speed.
Physicians utilize this test to assess active bone loss, diagnose metabolic bone disorders, and monitor the effectiveness of anti-resorptive medications like bisphosphonates in patients undergoing osteoporosis treatment.

The Beta-2 Crosslaps (CTx-1) EDTA Plasma test is a specialized blood test used to check your bone health.
When your body breaks down old bone, tiny protein pieces called CTx-1 are released into your bloodstream. By using an EDTA plasma tube (a special vial that keeps the blood sample stable), laboratories can measure how fast your bones are breaking down.
Doctors use this test primarily to diagnose and monitor osteoporosis (weak, brittle bones) and to see how well treatments for bone loss are working. High levels mean bone is breaking down faster than it should.